Literature DB >> 27341536

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research.

Alexander E Stover1, Siranush Herculian1, Maria G Banuelos1, Samantha L Navarro1, Michael P Jenkins1, Philip H Schwartz2.   

Abstract

This paper describes how to use a custom manufactured, commercially available enclosed cell culture system for basic and preclinical research. Biosafety cabinets (BSCs) and incubators have long been the standard for culturing and expanding cell lines for basic and preclinical research. However, as the focus of many stem cell laboratories shifts from basic research to clinical translation, additional requirements are needed of the cell culturing system. All processes must be well documented and have exceptional requirements for sterility and reproducibility. In traditional incubators, gas concentrations and temperatures widely fluctuate anytime the cells are removed for feeding, passaging, or other manipulations. Such interruptions contribute to an environment that is not the standard for cGMP and GLP guidelines. These interruptions must be minimized especially when cells are utilized for therapeutic purposes. The motivation to move from the standard BSC and incubator system to a closed system is that such interruptions can be made negligible. Closed systems provide a work space to feed and manipulate cell cultures and maintain them in a controlled environment where temperature and gas concentrations are consistent. This way, pluripotent and multipotent stem cells can be maintained at optimum health from the moment of their derivation all the way to their eventual use in therapy.

Entities:  

Mesh:

Year:  2016        PMID: 27341536      PMCID: PMC4927770          DOI: 10.3791/53685

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

1.  Hypoxia enhances the generation of induced pluripotent stem cells.

Authors:  Yoshinori Yoshida; Kazutoshi Takahashi; Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2009-08-27       Impact factor: 24.633

Review 2.  Stem cell therapies for the lysosomal storage diseases - the quintessential neurodegenerative diseases.

Authors:  Philip Hitchins Schwartz; David Joseph Brick
Journal:  Curr Stem Cell Res Ther       Date:  2008-05       Impact factor: 3.828

3.  Derivation of induced pluripotent stem cells by lentiviral transduction.

Authors:  Hubert E Nethercott; David J Brick; Philip H Schwartz
Journal:  Methods Mol Biol       Date:  2011

4.  Adaptation of human pluripotent stem cells to feeder-free conditions in chemically defined medium with enzymatic single-cell passaging.

Authors:  Alexander E Stover; Philip H Schwartz
Journal:  Methods Mol Biol       Date:  2011

5.  Real-time monitoring of non-viable airborne particles correlates with airborne colonies and represents an acceptable surrogate for daily assessment of cell-processing cleanroom performance.

Authors:  Jay S Raval; Eileen Koch; Albert D Donnenberg
Journal:  Cytotherapy       Date:  2012-07-02       Impact factor: 5.414

6.  The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery.

Authors:  David J Brick; Hubert E Nethercott; Samantha Montesano; Maria G Banuelos; Alexander E Stover; Soleil Sun Schutte; Diane K O'Dowd; Randi J Hagerman; Michele Ono; David R Hessl; Flora Tassone; Philip H Schwartz
Journal:  Stem Cells Transl Med       Date:  2014-10-01       Impact factor: 6.940

7.  Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes.

Authors:  Francesca Pistollato; Hui-Ling Chen; Philip H Schwartz; Giuseppe Basso; David M Panchision
Journal:  Mol Cell Neurosci       Date:  2007-04-12       Impact factor: 4.314

8.  Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling.

Authors:  Alexander E Stover; David J Brick; Hubert E Nethercott; Maria G Banuelos; Lei Sun; Diane K O'Dowd; Philip H Schwartz
Journal:  J Neurosci Res       Date:  2013-07-26       Impact factor: 4.164

9.  Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma.

Authors:  Francesca Pistollato; Hui-Ling Chen; Brian R Rood; Hui-Zhen Zhang; Domenico D'Avella; Luca Denaro; Marina Gardiman; Geertruy te Kronnie; Philip H Schwartz; Elena Favaro; Stefano Indraccolo; Giuseppe Basso; David M Panchision
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

Review 10.  The potential of stem cell therapies for neurological diseases.

Authors:  Philip H Schwartz
Journal:  Expert Rev Neurother       Date:  2006-02       Impact factor: 4.618

View more
  2 in total

Review 1.  Bio-collections in autism research.

Authors:  Jamie Reilly; Louise Gallagher; June L Chen; Geraldine Leader; Sanbing Shen
Journal:  Mol Autism       Date:  2017-07-10       Impact factor: 7.509

2.  A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia.

Authors:  Nejla Erkilic; Vincent Gatinois; Simona Torriano; Pauline Bouret; Carla Sanjurjo-Soriano; Valerie De Luca; Krishna Damodar; Nicolas Cereso; Jacques Puechberty; Rocio Sanchez-Alcudia; Christian P Hamel; Carmen Ayuso; Isabelle Meunier; Franck Pellestor; Vasiliki Kalatzis
Journal:  Cells       Date:  2019-09-11       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.